Evidence-based, pharmacological treatment guideline for depression in Korea, revised edition.
This paper aims to introduce, summarize, and emphasize the importance of the 'Evidence-Based, Pharmacological Treatment Guideline for Depression in Korea, Revised Edition'. The guideline broadly covers most aspects of the pharmacological treatment of patients in Korea diagnosed with moderate to severe major depression according to the DSM-IV TR. The guideline establishment process involved determining and answering a number of key questions, searching and selecting publications, evaluating recommendations, preparing guideline drafts, undergoing external expert reviews, and obtaining approval. A guideline adaptation process was conducted for the revised edition. The guideline strongly recommends pharmacological treatment considered appropriate to the current clinical situation in Korea, and should be considered helpful when selecting the appropriate pharmacological treatment of patients diagnosed with major depressive disorder. Therefore, the wide distribution of this guideline is recommended.
['Won|Eunsoo|E|0000-0001-6825-032X', 'Park|Seon-Cheol|SC|0000-0003-3691-4624', 'Han|Kyu-Man|KM|0000-0003-4837-6173', 'Sung|Seung-Hwan|SH|0000-0003-1680-5113', 'Lee|Hwa-Young|HY|0000-0002-2749-6232', 'Paik|Jong-Woo|JW|0000-0002-1804-8497', 'Jeon|Hong Jin|HJ|0000-0002-6126-542X', 'Lee|Moon-Soo|MS|0000-0003-0729-6943', 'Shim|Se-Hoon|SH|0000-0002-3137-6591', 'Ko|Young-Hoon|YH|0000-0002-5352-2158', 'Lee|Kang-Joon|KJ|0000-0001-8867-0276', 'Han|Changsu|C|0000-0002-4021-8907', 'Ham|Byung-Joo|BJ|0000-0002-0108-2058', 'Choi|Joonho|J|0000-0003-0597-0877', 'Hwang|Tae-Yeon|TY|0000-0002-5973-4418', 'Oh|Kang-Seob|KS|0000-0001-9850-1898', 'Hahn|Sang-Woo|SW|0000-0003-1662-5438', 'Park|Yong-Chon|YC|0000-0002-3019-5748', 'Lee|Min-Soo|MS|0000-0002-3483-4375', '|||']
D000928:Antidepressive Agents D014150:Antipsychotic Agents D016208:Databases, Factual D003863:Depression D004361:Drug Tolerance D055317:Evidence-Based Practice D006801:Humans D008996:Monoamine Oxidase Inhibitors D014179:Neurotransmitter Uptake Inhibitors D015990:Placebo Effect D011618:Psychotic Disorders D056910:Republic of Korea D012720:Severity of Illness Index
Pharmacological Treatment Guideline Depression Korea